REQUEST A DEMO
Total
USD $0.00
Search more companies

Ceska Lekarna Holding, A.S. (Czech Republic)

Main Activities: Pharmacies and Drug Stores
Full name: Ceska Lekarna Holding, A.S. Profile Updated: April 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Ceska Lekarna Holding a.s. (CHL) was founded in 2009 and it manages the operations the pharmacies Dr. Max in the Czech Republic. The company supplies goods to its entities though its sister distribution company ViaPharma and three logistic centres - in Prague, Brno and Ostrava. The company also offers on-line orders and delivery through its on-line store Dr.Max. In the Czech Republic, CLH manages over 400 branches, which is near 15% of the local pharmacy market.

Headquarters
Nove sady 996/25
Brno; Jihomoravsky; Postal Code: 60200

Contact Details: Purchase the Ceska Lekarna Holding, A.S. report to view the information.

Website: http://www.drmax.cz

Basic Information
Total Employees:
Purchase the Ceska Lekarna Holding, A.S. report to view the information.
Outstanding Shares:
Purchase the Ceska Lekarna Holding, A.S. report to view the information.
Registered Capital:
Purchase the Ceska Lekarna Holding, A.S. report to view the information.
Financial Auditors:
Purchase the Ceska Lekarna Holding, A.S. report to view the information.
Incorporation Date:
January 12, 2009
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
Vice Chairman of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Ceska Lekarnaa.s.
100%
Dracena S.R.O.
100%
Dum Zdravi Spol. S R.O. (Brno)
100%
Company Performance
Financial values in the chart are available after Ceska Lekarna Holding, A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
6.96%
Total operating revenue
8.79%
Operating profit (EBIT)
1.52%
EBITDA
5.43%
Net Profit (Loss) for the Period
11.69%
Total assets
6.34%
Total equity
10.37%
Operating Profit Margin (ROS)
-0.24%
Net Profit Margin
0.11%
Return on Equity (ROE)
0.13%
Debt to Equity Ratio
-18.78%
Quick Ratio
0.13%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?